Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 6/2017

01-11-2017 | Original Article

Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry

Authors: Dominique Kosk, Holly Kramer, Amy Luke, Pauline Camacho, Pascal Bovet, Jacob Plange Rhule, Terrence Forrester, Myles Wolf, Chris Sempos, Michal L. Melamed, Lara R. Dugas, Richard Cooper, Ramon Durazo-Arvizu

Published in: Journal of Bone and Mineral Metabolism | Issue 6/2017

Login to get access

Abstract

Fibroblast growth factor-23 (FGF23), a phosphaturic hormone secreted mainly by osteocytes, maintains serum phosphate levels within a tight range by promoting phosphaturia. Previous studies have mainly focused on the link between FGF23 levels and dietary intake of phosphate, but other dietary factors may also influence FGF23 levels. This cross-sectional study pooled three populations of young adults with African ancestry (452 in Chicago, IL, USA; 477 in Victoria, Seychelles; and 482 in Kumasi, Ghana) with estimated glomerular filtration rate >80 ml/min/1.73 m2 to examine the association of dietary factors based on two 24-h recalls with FGF23 levels measured using a C-terminal assay. Linear regression was used to examine the association between log-transformed FGF23 levels and quartiles of calorie-adjusted dietary factors with adjustment for covariates. In the pooled sample of 1411 study participants, the mean age was 35.2 (6.2) years and 45.3% were male. Median plasma C-terminal FGF23 values in relative units (RU)/ml were 59.5 [interquartile range (IQR) 44.1, 85.3] in the USA, 43.2 (IQR 33.1, 57.9) in Seychelles, and 34.0 (IQR 25.2, 50.4) in Ghana. With adjustment for covariates, increasing quartiles of calcium and animal protein and decreasing quartiles of vegetable protein, fiber, and magnesium intake were associated with significantly higher FGF23 levels compared to the lowest quartile. After further adjustment for dietary factors, significant trends in FGF23 levels were noted only for quartiles of calcium, fiber, and magnesium intake (P < 0.001). Dietary factors other than phosphate are associated with FGF23 levels in young adults.
Literature
1.
go back to reference Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519–1524CrossRefPubMed Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519–1524CrossRefPubMed
2.
go back to reference Antoniucci DM, Yamashita T, Portale AA (2006) Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 91:3144–3149CrossRefPubMed Antoniucci DM, Yamashita T, Portale AA (2006) Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 91:3144–3149CrossRefPubMed
3.
go back to reference Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS (2006) Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 21:1187–1196CrossRefPubMed Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS (2006) Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 21:1187–1196CrossRefPubMed
4.
go back to reference Tatsumi S, Miyagawa A, Kaneko I, Shiozaki Y, Segawa H, Miyamoto K (2016) Regulation of renal phosphate handling: inter-organ communication in health and disease. J Bone Miner Metab 34:1–10CrossRefPubMed Tatsumi S, Miyagawa A, Kaneko I, Shiozaki Y, Segawa H, Miyamoto K (2016) Regulation of renal phosphate handling: inter-organ communication in health and disease. J Bone Miner Metab 34:1–10CrossRefPubMed
5.
go back to reference Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukomoto S, Yamashita T (2003) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Min Res 19:429CrossRef Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukomoto S, Yamashita T (2003) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Min Res 19:429CrossRef
6.
go back to reference Yuen SN, Kramer H, Luke A, Bovet P, Plange-Rhule J, Forrester T, Wolf M, Camacho P, Harders R, Dugas L, Cooper R, Durazo-Arvizu R (2016) Fibroblast growth factor (FGF-23) levels differ across populations by degree of industrialization. J Clin Endocrinol Metab 101:2246–2253CrossRefPubMedPubMedCentral Yuen SN, Kramer H, Luke A, Bovet P, Plange-Rhule J, Forrester T, Wolf M, Camacho P, Harders R, Dugas L, Cooper R, Durazo-Arvizu R (2016) Fibroblast growth factor (FGF-23) levels differ across populations by degree of industrialization. J Clin Endocrinol Metab 101:2246–2253CrossRefPubMedPubMedCentral
7.
go back to reference Eckberg K, Kramer H, Wolf M, Durazo-Arvizu R, Tayo B, Luke A, Cooper R (2015) Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry. Nephrol Dial Transplant 30:630–635CrossRefPubMed Eckberg K, Kramer H, Wolf M, Durazo-Arvizu R, Tayo B, Luke A, Cooper R (2015) Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry. Nephrol Dial Transplant 30:630–635CrossRefPubMed
8.
go back to reference Torre M, Rodriguez AR, Saura-Calixto F (1991) Effects of dietary fiber and phytic acid on mineral availability. Crit Rev Food Sci Nutr 30:1–22CrossRefPubMed Torre M, Rodriguez AR, Saura-Calixto F (1991) Effects of dietary fiber and phytic acid on mineral availability. Crit Rev Food Sci Nutr 30:1–22CrossRefPubMed
9.
go back to reference di Giuseppe R, Kuhn T, Hirche F, Buijsse B, Dierkes J, Fritsche A, Kaaks R, Boeing H, Stangl GI, Weikert C (2015) Potential predictors of plasma fibroblast growth factor 23 concentrations: cross-sectional analysis in the EPIC-Germany Study. PLoS One 10:e0133580 (Electronic Resource) CrossRefPubMedPubMedCentral di Giuseppe R, Kuhn T, Hirche F, Buijsse B, Dierkes J, Fritsche A, Kaaks R, Boeing H, Stangl GI, Weikert C (2015) Potential predictors of plasma fibroblast growth factor 23 concentrations: cross-sectional analysis in the EPIC-Germany Study. PLoS One 10:e0133580 (Electronic Resource) CrossRefPubMedPubMedCentral
10.
go back to reference Baia LC, Van den Berg E, Vervloet MG, Heilberg IP, Navis G, Bakker SJ, Geleijnse JM, Kromhout D, Soedamah-Muthu SS, De Borst MH, NIGRAM consortium (2014) Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients. Nutr Metab Cardiovasc Dis 24:1310–1316CrossRefPubMed Baia LC, Van den Berg E, Vervloet MG, Heilberg IP, Navis G, Bakker SJ, Geleijnse JM, Kromhout D, Soedamah-Muthu SS, De Borst MH, NIGRAM consortium (2014) Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients. Nutr Metab Cardiovasc Dis 24:1310–1316CrossRefPubMed
11.
go back to reference Vervloet MG, van Ittersum FJ, Buttler RM, Heijboer AC, Blankenstein MA, ter Wee PM (2011) Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol 6:383–389CrossRefPubMedPubMedCentral Vervloet MG, van Ittersum FJ, Buttler RM, Heijboer AC, Blankenstein MA, ter Wee PM (2011) Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol 6:383–389CrossRefPubMedPubMedCentral
12.
go back to reference Cooper R, Forrester T, Ogunbiyi O, Muffinda J (1998) Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators. J Hypertens 16:571–575CrossRefPubMed Cooper R, Forrester T, Ogunbiyi O, Muffinda J (1998) Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators. J Hypertens 16:571–575CrossRefPubMed
13.
go back to reference Luke A, Bovet P, Forrester TE, Lambert EV, Plange-Rhule J, Schoeller DA, Dugas LR, Durazo-Arvizu RA, Shoham D, Cooper RS, Brage S, Ekelund U, Steyn NP (2011) Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk. BMC Public Health 11:927CrossRefPubMedPubMedCentral Luke A, Bovet P, Forrester TE, Lambert EV, Plange-Rhule J, Schoeller DA, Dugas LR, Durazo-Arvizu RA, Shoham D, Cooper RS, Brage S, Ekelund U, Steyn NP (2011) Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk. BMC Public Health 11:927CrossRefPubMedPubMedCentral
14.
go back to reference Steyn NP, Nel JH, Parker WA, Ayah R, Mbithe D (2011) Dietary, social, and environmental determinants of obesity in Kenyan women. Scand J Public Health 39:88–97CrossRefPubMed Steyn NP, Nel JH, Parker WA, Ayah R, Mbithe D (2011) Dietary, social, and environmental determinants of obesity in Kenyan women. Scand J Public Health 39:88–97CrossRefPubMed
15.
go back to reference Orcholski L, Luke A, Plange-Rhule J, Bovet P, Forrester TE, Lambert EV, Dugas LR, Kettmann E, Durazo-Arvizu RA, Cooper RS, Schoeller DA (2015) Under-reporting of dietary energy intake in five populations of the African diaspora. Br J Nutr 113:464–472CrossRefPubMedPubMedCentral Orcholski L, Luke A, Plange-Rhule J, Bovet P, Forrester TE, Lambert EV, Dugas LR, Kettmann E, Durazo-Arvizu RA, Cooper RS, Schoeller DA (2015) Under-reporting of dietary energy intake in five populations of the African diaspora. Br J Nutr 113:464–472CrossRefPubMedPubMedCentral
16.
go back to reference Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228SPubMed Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228SPubMed
17.
go back to reference Curhan GC, Willet WC, Knight EL, Stampfer MJ (2004) Dietary factors and the risk of incident kidney stones in younger women. Arch Intern Med 164:885–891CrossRefPubMed Curhan GC, Willet WC, Knight EL, Stampfer MJ (2004) Dietary factors and the risk of incident kidney stones in younger women. Arch Intern Med 164:885–891CrossRefPubMed
18.
go back to reference Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS, CKD-EPI I (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20–29CrossRefPubMedPubMedCentral Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS, CKD-EPI I (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20–29CrossRefPubMedPubMedCentral
19.
go back to reference Tukey J (1957) On the comparative anatomy of transformations. Ann Math Sci 28:602–632 Tukey J (1957) On the comparative anatomy of transformations. Ann Math Sci 28:602–632
20.
go back to reference Walling MW (1977) Intestinal Ca and phosphate transport: differential responses to vitamin D3 metabolites. Am J Physiol 233:E488–E494PubMed Walling MW (1977) Intestinal Ca and phosphate transport: differential responses to vitamin D3 metabolites. Am J Physiol 233:E488–E494PubMed
21.
go back to reference Braithwaite V, Jarjou LM, Goldberg GR, Prentice A (2012) Iron status and fibroblast growth factor-23 in Gambian children. Bone (NY) 50:1351–1356CrossRef Braithwaite V, Jarjou LM, Goldberg GR, Prentice A (2012) Iron status and fibroblast growth factor-23 in Gambian children. Bone (NY) 50:1351–1356CrossRef
22.
go back to reference Sullivan CM, Leon JB, Sehgal AR (2007) Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Renal Nutr 17:350–354CrossRef Sullivan CM, Leon JB, Sehgal AR (2007) Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Renal Nutr 17:350–354CrossRef
23.
go back to reference Scialla JJ, Appel LJ, Wolf M, Yang W, Zhang X, Sozio SM, Miller ER 3rd, Bazzano LA, Cuevas M, Glenn MJ, Lustigova E, Kallem RR, Porter AC, Townsend RR, Weir MR, Anderson CA (2012) Chronic Renal Insufficiency Cohort-CRIC Study Group (2012) Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study. J Renal Nutr 22:379–388.e1 Scialla JJ, Appel LJ, Wolf M, Yang W, Zhang X, Sozio SM, Miller ER 3rd, Bazzano LA, Cuevas M, Glenn MJ, Lustigova E, Kallem RR, Porter AC, Townsend RR, Weir MR, Anderson CA (2012) Chronic Renal Insufficiency Cohort-CRIC Study Group (2012) Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study. J Renal Nutr 22:379–388.e1
24.
go back to reference Moe SM, Zidehsarai MP, Chambers MA, Jackman LA, Radcliffe JS, Trevino LL, Donahue SE, Asplin JR (2011) Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 6:257–264CrossRefPubMedPubMedCentral Moe SM, Zidehsarai MP, Chambers MA, Jackman LA, Radcliffe JS, Trevino LL, Donahue SE, Asplin JR (2011) Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 6:257–264CrossRefPubMedPubMedCentral
25.
go back to reference Moorthi RN, Armstrong CL, Janda K, Ponsler-Sipes K, Asplin JR, Moe SM (2014) The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease. Am J Nephrol 40:582–591CrossRefPubMed Moorthi RN, Armstrong CL, Janda K, Ponsler-Sipes K, Asplin JR, Moe SM (2014) The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease. Am J Nephrol 40:582–591CrossRefPubMed
26.
go back to reference Kim DJ, Holowaty EJ (2003) Brief, validated survey instruments for the measurement of fruit and vegetable intakes in adults: a review. Prev Med 36:440–447CrossRefPubMed Kim DJ, Holowaty EJ (2003) Brief, validated survey instruments for the measurement of fruit and vegetable intakes in adults: a review. Prev Med 36:440–447CrossRefPubMed
28.
go back to reference Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD (2010) Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5:519–530CrossRefPubMed Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD (2010) Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5:519–530CrossRefPubMed
29.
go back to reference Kobayashi K, Imanishi Y, Miyauchi A, Onoda N, Kawata T, Tahara H, Goto H, Miki T, Ishimura E, Sugimoto T, Ishikawa T, Inaba M, Nishizawa Y (2006) Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol 154:93–99CrossRefPubMed Kobayashi K, Imanishi Y, Miyauchi A, Onoda N, Kawata T, Tahara H, Goto H, Miki T, Ishimura E, Sugimoto T, Ishikawa T, Inaba M, Nishizawa Y (2006) Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol 154:93–99CrossRefPubMed
30.
go back to reference Wesseling-Perry K, Wang H, Elashoff R, Gales B, Juppner H, Salusky IB (2014) Lack of FGF23 response to acute changes in serum calcium and PTH in humans. J Clin Endocrinol Metab 99:E1951–E1956CrossRefPubMedPubMedCentral Wesseling-Perry K, Wang H, Elashoff R, Gales B, Juppner H, Salusky IB (2014) Lack of FGF23 response to acute changes in serum calcium and PTH in humans. J Clin Endocrinol Metab 99:E1951–E1956CrossRefPubMedPubMedCentral
31.
go back to reference Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block GA (2015) Rationale and Approaches to phosphate and fibroblast growth factor 23 reduction in CKD. J Am Soc Nephrol 26:2328–2339CrossRefPubMedPubMedCentral Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block GA (2015) Rationale and Approaches to phosphate and fibroblast growth factor 23 reduction in CKD. J Am Soc Nephrol 26:2328–2339CrossRefPubMedPubMedCentral
32.
go back to reference Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM (2012) Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23:1407–1415CrossRefPubMedPubMedCentral Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM (2012) Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23:1407–1415CrossRefPubMedPubMedCentral
33.
go back to reference Khouzam NM, Wesseling-Perry K, Salusky IB (2015) The role of bone in CKD-mediated mineral and vascular disease. Pediatr Nephrol 30:1379–1388CrossRefPubMed Khouzam NM, Wesseling-Perry K, Salusky IB (2015) The role of bone in CKD-mediated mineral and vascular disease. Pediatr Nephrol 30:1379–1388CrossRefPubMed
34.
go back to reference Rodriguez-Ortiz ME, Lopez I, Munoz-Castaneda JR, Martinez-Moreno JM, Ramirez AP, Pineda C, Canalejo A, Jaeger P, Aguilera-Tejero E, Rodriguez M, Felsenfeld A, Almaden Y (2012) Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol 23:1190–1197CrossRefPubMedPubMedCentral Rodriguez-Ortiz ME, Lopez I, Munoz-Castaneda JR, Martinez-Moreno JM, Ramirez AP, Pineda C, Canalejo A, Jaeger P, Aguilera-Tejero E, Rodriguez M, Felsenfeld A, Almaden Y (2012) Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol 23:1190–1197CrossRefPubMedPubMedCentral
35.
36.
go back to reference Covic A, Passlick-Deetjen J, Kroczak M, Buschges-Seraphin B, Ghenu A, Ponce P, Marzell B, de Francisco AL (2013) A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study. Nephrol Dial Transpl 28:2383–2392CrossRef Covic A, Passlick-Deetjen J, Kroczak M, Buschges-Seraphin B, Ghenu A, Ponce P, Marzell B, de Francisco AL (2013) A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study. Nephrol Dial Transpl 28:2383–2392CrossRef
37.
go back to reference de Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, Scholz C, Ponce P, Passlick-Deetjen J (2010) Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 25:3707–3717CrossRefPubMedPubMedCentral de Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, Scholz C, Ponce P, Passlick-Deetjen J (2010) Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 25:3707–3717CrossRefPubMedPubMedCentral
38.
go back to reference David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M (2016) Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 89:135–146CrossRefPubMedPubMedCentral David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M (2016) Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 89:135–146CrossRefPubMedPubMedCentral
39.
go back to reference Wolf M, Koch TA, Bregman DB (2013) Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 28:1793–1803CrossRefPubMed Wolf M, Koch TA, Bregman DB (2013) Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 28:1793–1803CrossRefPubMed
40.
go back to reference Wolf M (2010) Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 21:1427–1435CrossRefPubMed Wolf M (2010) Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 21:1427–1435CrossRefPubMed
Metadata
Title
Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry
Authors
Dominique Kosk
Holly Kramer
Amy Luke
Pauline Camacho
Pascal Bovet
Jacob Plange Rhule
Terrence Forrester
Myles Wolf
Chris Sempos
Michal L. Melamed
Lara R. Dugas
Richard Cooper
Ramon Durazo-Arvizu
Publication date
01-11-2017
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 6/2017
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-016-0804-5

Other articles of this Issue 6/2017

Journal of Bone and Mineral Metabolism 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.